Newswise: Lasting Immunity and Protection from New Single-Shot, Room-Temperature Stable COVID-19 Vaccine

Newswise: Lasting Immunity and Protection from New Single-Shot, Room-Temperature Stable COVID-19 Vaccine. “With support from Novartis Gene Therapies, the AAVCOVID vaccine was shown to be producible with efficient, scalable, and industry-established manufacturing processes. The investigators further demonstrated that the vaccine product is stable at room-temperature storage conditions for up to one month, facilitating potential future distribution of the vaccine.”

Leave a Reply

%d bloggers like this: